Hui Shao
Director/Board Member at Hangzhou Adlai Nortye Biopharma Co. Ltd.
Profile
Hui Shao currently works at Hangzhou Adlai Nortye Biopharma Co. Ltd., as Non-Executive Director from 2020 and Adlai Nortye USA, Inc., as Director from 2020.
Mr. Shao also formerly worked at Adlai Nortye Ltd., as Non-Executive Director.
Mr. Shao received his undergraduate degree in 1993 from Northeast Normal University.
Hui Shao active positions
| Companies | Position | Start |
|---|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
 Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Director/Board Member | 2020-01-31 |
| Adlai Nortye USA, Inc. | Director/Board Member | 2019-12-31 |
Former positions of Hui Shao
| Companies | Position | End |
|---|---|---|
| ADLAI NORTYE LTD. | Director/Board Member | - |
Training of Hui Shao
| Northeast Normal University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ADLAI NORTYE LTD. | Commercial Services |
| Private companies | 2 |
|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
| Adlai Nortye USA, Inc. |
- Stock Market
- Insiders
- Hui Shao
